Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.

Autor: Qingqing Zhou, Phoa, Athena F., Abbassi, Ramzi H., Hoque, Monira, Reekie, Tristan A., Font, Josep S., Ryan, Renae M., Stringer, Brett W., Day, Bryan W., Johns, Terrance G., Munoz, Lenka, Kassiou, Michael
Zdroj: Journal of Medicinal Chemistry; 3/9/2017, Vol. 60 Issue 5, p2052-2070, 19p
Databáze: Supplemental Index